Efficacy and safety of remimazolam bolus injection during induction of general anesthesia - Remimazolam bolus injection

Miyoshi Hirotsugu0 个研究点目标入组 69 人开始时间: 2023年8月17日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1. Patients undergoing scheduled non-cardiac surgeries under general anesthesia
•2. Patients aged 18 to 80
•3. Patients with ASA-PS classification 1 or 2
•4. Patients with BMI 18.5 to 30
•5. Patients who can understand our explanation well enough, agree and sign the consent forms of their own will

•1. Patients with heavy use of alcohol (over 60 g per day)
•2. Patients who have or previously had an addiction to alcohol or any other drugs
•3. Patients with common use of benzodiazepines
•4. Patients with acute angle-closed glaucoma, myasthenia gravis or hypersensitivity to remimazolam
•5. Patients with severe mental disorders
•6. Patients with encephalopathy
•7. Patients who are pregnant or lactating
•8. Researchers who are directly involved in this study or other clinical studies, or their families
•9. Patients who are judged inappropriate for this study

发起方

Miyoshi Hirotsugu